Bulgaria’s competition regulator announced that it gave the green light to local pharmaceuticals distributor Bulpharma to acquire a 100% stake in automotive dealer N Auto Sofia from Auto Union.
Under the terms of the deal, Bulpharma will also acquire indirectly 51% interest in each Espace Auto and EA Properties, both part of N Auto Sofia, the Commission for Protection of Competition (CPC) stated in a decision published on Friday, July 23.
The acquisition will not have an impact on any of the relevant markets in the country, the CPC stated.
Interested parties can challenge the regulator’s decision before Sofia Region Administrative Court until August 6.
Bulpharma’s most recent financial report filed with the commercial register showed that at the end of 2018 the Bulpharma group consisted of 27 companies, including the parent company and companies active in healthcare, transportation, real estate, and hospitality.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Mehta Questions Both Sides in Landmark Google Antitrust Case
May 2, 2024 by
CPI
FCC Urges Urgent Funding for Removal of Chinese Telecom Equipment from U.S. Networks
May 2, 2024 by
CPI
Former Pioneer CEO Facing Potential Criminal Charges For Colluding With OPEC
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI